-

Anthem’s Board Welcomes Susan Dodson DeVore as New Director

INDIANAPOLIS--(BUSINESS WIRE)--The Board of Directors of Anthem, Inc. (NYSE: ANTM) announced that Susan Dodson DeVore has joined the Board.

Ms. DeVore’s decades of leadership in the healthcare and financial industries demonstrates her focus to create and develop solutions that promote the efficiency and sustainability of healthcare models.

Ms. DeVore recently retired after more than a decade as Chief Executive Officer and Director of Premier, Inc., which operates as a healthcare supply chain, technology and performance improvement company serving over 4,100 hospitals and health systems and 200,000 other providers of healthcare. Under her leadership, Premier had a successful initial public offering and has been publicly recognized for its ethical practices, technology innovations, quality of overall performance improvement consulting, and work environment.

Ms. DeVore also has over twenty years of finance, strategy and healthcare consulting experience, including as Partner and Region Leader for the Health Care Consulting Practice at Ernst & Young. She has been named multiple times to Modern Healthcare's 100 Most Influential People and Top 25 Women in Healthcare lists. Ms. DeVore currently serves on the board of UNUM Group and previously chaired the Healthcare Leadership Council and co-chaired the National Academy of Medicine’s Value and Science Driven Health Care Collaborative.

“We are pleased to welcome Susan to our Board of Directors,” said Elizabeth Tallett, Chair, Anthem Board of Directors. “Her leadership in driving innovation through collaborations with healthcare providers and other key stakeholders will provide valuable insights to our Board as the Company continues to pursue its purpose of improving the health of humanity.”

About Anthem, Inc.

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 117 million people, including more than 44 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

Contacts

Investor Relations:
Stephen Tanal
Stephen.tanal@anthem.com

Media Relations:
Michelle Vanstory
Michelle.vanstory@anthem.com

Anthem, Inc.

NYSE:ANTM

Release Versions

Contacts

Investor Relations:
Stephen Tanal
Stephen.tanal@anthem.com

Media Relations:
Michelle Vanstory
Michelle.vanstory@anthem.com

More News From Anthem, Inc.

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-3...

Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs. As members evaluate Medicare coverage for 2027, many want to understand their benefits, connect to care, manage healthcare costs and know where to turn for support throu...

Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations. "Our second quarter results exceeded our outlook, supported by disciplined execution and improved operating performance across our diversified portfolio. We are raising our 2026 adjusted EPS guidance to at least $27.00 and accelerating targeted investments in the capabilities that matter most: medical cost management, member experience, provider connectivity, operating ef...
Back to Newsroom